Comparing clot-busting drugs for lung infections
Part of Lungs & breathing clinical trials.
This trial tests two combinations of medicines for people with infected fluid around the lung that isn't draining well through a chest tube. The goal is to see which combination works better to clear the infection and improve recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a confirmed lung infection (empyema or complicated parapneumonic effusion) with poor fluid drainage (less than 150 ml in 24 hours) after a chest tube is placed
- You have at least two signs of infection (like fever, high CRP or white blood cell count, or complex fluid seen on ultrasound)
- Your infected fluid meets one or more lab criteria (e.g., looks like pus, has high LDH, low pH, low glucose, or positive culture)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a lower dose of alteplase (a clot-busting medicine) given into the chest can improve healing of infected pleural fluid when drainage is incomplete. It may help reduce dosing-related side effects while still helping clear the infection-related fluid.
This trial compares using a special camera to look inside your chest (medical thoracoscopy) with standard care to treat infections in the fluid around the lungs. It aims to see if this procedure helps clear the infection better, possibly reducing the need for more invasive surgery or a longer hospital stay.
This study tests using a thin tube with a camera (thoracoscopy) to treat early-stage pleural infection, an infection in the space around the lungs. It may help drain the infection better and possibly reduce the need for more invasive surgery.
This study tests whether rinsing the infected space around the lung with salt water (saline) before giving enzyme medicine helps clear the infection better than just the enzyme medicine alone. It's for people with a serious lung infection (empyema) that requires a chest tube.
This study tests a two-step treatment for infected fluid around the lungs called empyema. It uses two medicines (tPA and DNase) given through your chest tube to break up and clear the fluid, which may help your lung expand and avoid surgery.
This study tests a two-medicine treatment (given through a chest tube) to help clear fluid around the lungs caused by TB or other infections. It aims to see if this treatment is safe and works well.
Hear when a new Pleural Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.